STOCK COMPARISON
Haw Par Corp vs Eli Lilly and: Fair Value & Quality
Both stocks run through our valuation models. Here is how Haw Par Corp (H02) and Eli Lilly and (LLY) compare, as of Aug 5, 2026.
As of Aug 5, 2026, Fair Value Calculator sees Haw Par Corp as the less overvalued of the two: Haw Par Corp trades at S$16.10 versus a fair value of S$8.53 (-47%), while Eli Lilly and trades at $1,149 versus $397 (-65%).
Haw Par Corp
H02.SG · SGD · Health Care
-47%
upside to fair value
overvalued
PriceS$16.10
Fair ValueS$8.53
Quality69/100
Eli Lilly and
LLY · USD · Health Care
-65%
upside to fair value
overvalued
Price$1,149
Fair Value$397
Quality74/100
Head-to-head numbers
Green value = the better side for that row (for valuation multiples: lower = cheaper).
Haw Par CorpEli Lilly and
Valuation
13.3×P/E (TTM)42.2×
11.96×P/S (TTM)14.67×
0.64×P/B39.94×
27.4×EV/EBITDA30.2×
—PEG1.54×
2.5%Dividend yield0.5%
S$0.40Dividend per share$6.23
Profitability
115%Net margin35%
33%Operating margin49%
6%Return on equity107%
1%Return on assets21%
Growth
-18%Revenue growth (YoY)56%
8.1%Avg. growth/yr (3Y)31.7%
15.7%Avg. growth/yr (5Y)21.6%
Balance & size
0.01×Debt / equity1.54×
$3BMarket cap$1.1T
expensiveGrowth qualitymixed
Haw Par Corp leads: 7 to 6 metric wins.
Dash = not meaningfully computable, for example with negative equity.
Quality in detail
The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.
Haw Par Corpof which business quality 68 · market factors 64
Eli Lilly andof which business quality 65 · market factors 75
ProfitabilityMargins and returns on capital today
37
85
Quality GrowthAre margins and returns improving?
53
86
CashflowEarnings quality: real cash, not paper profit
70
51
Fin. StrengthBalance sheet, leverage, solvency risk
92
53
InvestmentDisciplined investing over empire-building
78
15
Low VolatilityCalm price path (market factor)
93
74
MomentumPrice trend over the last 3–12 months (market factor)
45
72
52W MomentumDistance to the 52-week high (market factor)
63
83
Net IssuanceBuybacks instead of dilution
82
93
What the models say
The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.
Haw Par Corp
DCF ModelsS$7.59
Earnings-BasedS$6.76
MultiplesS$8.26
Asset-BasedS$12.99
Growth DCFS$6.83
Economic ProfitS$10.81
Growth EarningsS$20.71
17 of 24 models see the stock below the current price.
Eli Lilly and
DCF Models$323
Earnings-Based$239
Dividend Discount$115
Multiples$303
Asset-Based$19.94
Growth DCF$171
Economic Profit$347
Growth Earnings$353
26 of 26 models see the stock below the current price.
Scenario ranges
From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.
Haw Par Corp
Bear S$7.24Fair Value S$8.53Bull S$10.36
S$16.10 = current price (white tick)
Eli Lilly and
Bear $222Fair Value $397Bull $582
$1,149 = current price (white tick)
Compare two other stocks
Tap a field and type again, ticker or company name.
Ranked within their sector
Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.
Haw Par Corp · Health Care
Quality score69 · Top 25%
Fair value upside-47% · below median
Eli Lilly and · Health Care
Quality score74 · Top 25%
Fair value upside-65% · below median
Bottom line
As of Aug 5, 2026, Fair Value Calculator sees Haw Par Corp as the less overvalued of the two: Haw Par Corp trades at S$16.10 versus a fair value of S$8.53 (-47%), while Eli Lilly and trades at $1,149 versus $397 (-65%).
Eli Lilly and has the higher quality score (74/100).
See the full analysis →
More comparisons
Popular match-ups from the same sectors, all with fair value and quality score.
Free · Top-25 report
See the undervalued quality stocks every month
Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.
A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.
